NIA-supported scientists have developed a new mouse model that produces a form of the human beta-amyloid protein, a hallmark of Alzheimer’s disease. An important research tool, mouse models enable the…
阅读更多
UCI MIND professor, David Sultzer, MD, and other investigators show a clinical benefit of an investigational antipsychotic drug, pimavanserin in reducing behavioral symptoms related to Alzheimer’s disease. The post David…
阅读更多
Contributed by Joshua Grill, PhD UCI MIND Director Joshua Grill, PhD co-authored an article in Nature Reviews Neurology about the FDA’s decision on Aduhelm. Read more on this below: Since…
阅读更多
UCI School of Biological Sciences Dean Frank LaFerla is co-senior author of a study involving a new genetically engineered mouse model that, unlike its predecessors, is based on the most…
阅读更多
Contributed by Vivek Swarup, PhD The brain is made up of billions of cells that are tightly coordinated in complex neural circuitry and are ultimately responsible for manifesting our memories,…
阅读更多
A crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it? STAT News – June 24, 2021 “When we enroll families in studies of treatments like…
阅读更多
People taking drugs that cross the blood-brain barrier experienced less cognitive decline June 21, 2021 The research conducted by Daniel Nation, UCI associate professor of psychological science, and Jean Ho,…
阅读更多
“My greatest concern is around people with families with Alzheimer’s disease,” said Joshua D. Grill, an Alzheimer’s researcher at the University of California at Irvine. “Few can afford the financial…
阅读更多
KATU News: “We all have to do more because this is about the most important medical problem we face as a society today,” said Dr. Josh Grill, a member of…
阅读更多
MarketWatch As we age, our already limited attention span shrinks even more. So it takes extra discipline for seniors to stay curious. … Craig Stark, , a memory researcher at…
阅读更多